Stay updated on Rituximab vs Cyclophosphamide in Severe MMP Clinical Trial
Sign up to get notified when there's something new on the Rituximab vs Cyclophosphamide in Severe MMP Clinical Trial page.

Latest updates to the Rituximab vs Cyclophosphamide in Severe MMP Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new footer revision note 'Revision: v3.3.3' was added, and the previous 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' entries were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedFooter revision updated from v3.3.1 to v3.3.2, a minor technical change that does not affect study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page shows Revision: v3.3.1 instead of Revision: v3.2.0. This is a minor UI/version update and does not affect study details or navigation.SummaryDifference0.0%

- Check48 days agoChange DetectedThe site-wide government funding status notice has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page content appears unchanged with regard to the study overview, intervention arms, inclusion/exclusion criteria, and primary/secondary outcomes.SummaryDifference0.3%

- Check90 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference2%

Stay in the know with updates to Rituximab vs Cyclophosphamide in Severe MMP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rituximab vs Cyclophosphamide in Severe MMP Clinical Trial page.